Objectives : -To determine whether reductions in mean arterial pressure (MAP) and heart rate (HR) induced by melatonin (MEL) in SHR are due to a modification of sympathetic functions and ␤-adrenergic receptor (ADR)-coupled adenylyl cyclase pathway in spontaneously hypertensive rats (SHR).
Responsiveness to many contractile agonists increase in deoxycorticosterone acetate (DOCA)-salt induced hypertension We tested the hypothesis that enhanced contractility of rat aorta to norepinephrine (NE) in DOCA-salt hypertension is causally related to increased expression and activity of COX-2. Thoracic aortic rings were obtained from uninephrectomized rats fed for 3 weeks on either normal (control), or 8% sodiumϩpotassium (experimental) diets. The control and experimental groups were implanted (s.c) with placebo and DOCA (100 mg) 21-day release pellets, respectively. Tissue force of rings bathed with physiologic salt solution (PSS) (37°C;5%CO 2 /95%O 2 ) were measured with FT 03 force transducers coupled to a Grass polygraph. Tail cuff pressures (mmHg) were 180 Ϯ 5/166 Ϯ 5 (DOCA-salt) versus 128 Ϯ 3/116 Ϯ 6 (Control) rats. NE (0.001-1 M) elicited contractions of endotheliumintact and denuded aortic rings; pD 2 values for intact vessels were 7.04 Ϯ 0.05 (Control) and 8.14 Ϯ 0.05 (DOCA). NS-398 (3 M),a COX-2-selective blocker, reduced NE contractions in Control (24 Ϯ 3%) and DOCA-salt (89 Ϯ 1.8%) aortic rings. Indomethacin (10 M), a dual COX-1/COX-2 blocker, failed to alter NE contractions in the control, but reduced the contractions of DOCA hypertensive vessels by 46 Ϯ 5%. Piroxicam (10 M), a COX-1-selective blocker did not alter NE contractions. Western blot analysis showed COX-2 immunoreactive bands (Ϸ70 kDa) and is significantly denser on densitometric units in DOCAsalt hypertensive versus control normotensive vessels. COX-1 protein expressions were not different in control normotensive and DOCA-salt hypertensive aortic vessels. We conclude: (1) that COX-2 expression increases significantly in DOCA-salt hypertension. (2) COX-2 mediates the production of a factor(s) that enhances rat aortic contractility.
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Key Words: DOCA-salt hypertension, COX-2 expression, Rat aorta We have previously reported that N--nitro-L-arginine-methyl ester (L-NAME)-induced hypertensive rats exhibited an enhanced expression of Gi proteins. In addition, losartan, AT1 receptor antagonist, has been shown to decrease L-NAME-induced increase in the blood pressure. The present study was designed to evaluate the involvement of AT1 receptor in L-NAME-induced alterations in blood pressure and G-protein adenylyl cyclase signaling pathway. L-NAME (70 mg/kg body weight), Losartan (10 mg/kg b.wt) alone or in combination were given orally for 4 weeks. Control group received only plain tap water. The expression of Gi␣-2 and Gi␣-3 proteins and mRNA was enhanced in L-NAME-treated rats which was reversed by losartan treatment. However, losartan alone did not alter the levels of Gi-␣ proteins or mRNA. On the other hand, the expression of Gs␣ was not altered by these treatments. Guanosine 5'-o-(3-thiophosphate) (GTP␥S)-stimulated adenylyl cyclase activity in both control and L-NAME-treated groups, but the extent of stimulation was significantly attenuated in L-NAME-treated rats, which was reversed by losartan. Similarly, stimulation of adenylyl cyclase exerted by isoproterenol, 5'-N-ethylcarboxamideadenosine (NECA) glucagon, forskolin and sodium fluoride were diminished in L-NAME-treated rats and were reversed by losartan treatment. On the other hand, inhibition of forskolin-stimulated enzyme activity by low concentrations of GTP␥S that was significantly enhanced in L-NAME-treated rats, was attenuated by losartan. In addition, oxotremorine-and angiotensin II-mediated inhibiton of adenylyl cyclase activity was completely attenuated in L-NAME-treated rats which was reversed by losartan. These results suggest the implication of AT1 receptor in L-NAME-induced enhanced expression of Gi␣ proteins and hypertension.
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